JC124

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

JC124 是一种特异性的 NLRP3 炎症小体抑制剂。JC124 具有抗炎和神经保护作用。

JC124 is a specific NLRP3 inflammasome inhibitor. JC124 has anti-inflammatory and neuroprotective effects.

JC124 shows selective inhibition of NLRP3 inflammasome formation and activation of caspase-1, and reduction of IL-1β both in vitro.

JC124 (100?mg/kg; i.p.; 4 doses; 30?min post-injury, 6, 24, and 30?h after TBI) treatment significantly decreases the number of injury-induced degenerating neurons, inflammatory cell response in the injured brain, and cortical lesion volume. JC124 also significantly reduces protein expression levels of NLRP3, ASC, IL-1 beta, TNFα, iNOS, and caspase-1.Animal Model:Adult male Sprague-Dawley rats (3-4-months-old) bearing traumatic brain injury (TBI) Dosage:100?mg/kg Administration:i.p.; 4 doses; 30?min post-injury, 6, 24, and 30?h after TBI Result:Significantly decreased the number of injury-induced degenerating neurons, inflammatory cell response in the injured brain, and cortical lesion volume.

——

NF-κB

NOD

NOD

——

——

1638611-48-9

382.86

C17H19ClN2O4S

>98% (HPLC)

In Vitro:?DMSO 中的溶解度 : 250 mg/mL (652.98 mM; 超声助溶 酸性条件溶解 (HCL 调节，pH≈3)

CNS(=O)(=O)c1ccc(CCNC(=O)c2cc(Cl)ccc2OC)cc1

——

(-20℃)

With Ice Pack

≥ 2 years